Article révisé par les pairs
Résumé : Objective: Levetiracetam (LEV) is an effective antiseizure medicine, but 10%–20% of people treated with LEV report psychiatric side-effects, and up to 1% may have psychotic episodes. Pharmacogenomic predictors of these adverse drug reactions (ADRs) have yet to be identified. We sought to determine the contribution of both common and rare genetic variation to psychiatric and behavioral ADRs associated with LEV. Methods: This case-control study compared cases of LEV-associated behavioral disorder (n = 149) or psychotic reaction (n = 37) to LEV-exposed people with no history of psychiatric ADRs (n = 920). All samples were of European ancestry. We performed genome-wide association study (GWAS) analysis comparing those with LEV ADRs to controls. We estimated the polygenic risk scores (PRS) for schizophrenia and compared cases with LEV-associated psychotic reaction to controls. Rare variant burden analysis was performed using exome sequence data of cases with psychotic reactions (n = 18) and controls (n = 122). Results: Univariate GWAS found no significant associations with either LEV-associated behavioural disorder or LEV-psychotic reaction. PRS analysis showed that cases of LEV-associated psychotic reaction had an increased PRS for schizophrenia relative to contr ols (p =.0097, estimate =.4886). The rare-variant analysis found no evidence of an increased burden of rare genetic variants in people who had experienced LEV-associated psychotic reaction relative to controls. Significance: The polygenic burden for schizophrenia is a risk factor for LEV-associated psychotic reaction. To assess the clinical utility of PRS as a predictor, it should be tested in an independent and ideally prospective cohort. Larger sample sizes are required for the identification of significant univariate common genetic signals or rare genetic signals associated with psychiatric LEV ADRs.

Documents en relation

DI-fusion

  • Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure Medications
    par Wolking, Stefan , Campbell, Ciarán , Stapleton, Caragh , McCormack, Mark , Delanty, Norman , Depondt, Chantal , Johnson, Michael , Koeleman, Bobby B.P.C. , Krause, Roland , Kunz, Wolfram W.S. , Marson, Anthony Guy , Sander, Josemir W , Sills, Graeme , Striano, Pasquale , Zara, Federico , Sisodiya, Sanjay , Cavalleri, Gianpiero , Lerche, Holger
    Publication 2021-06
  • Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrin.
    par Boothman, Isabelle , Clayton, Lisa M S , McCormack, Mark , Driscoll, Alexandra McKibben , Stevelink, Remi , Moloney, Patrick , Krause, Roland , Kunz, Wolfram W.S. , Diehl, Sarah , O'Brien, Terence , Sills, Graeme , de Haan, Gerrit Jan , Zara, Federico , Koeleman, B.P.C. , Depondt, Chantal , Marson, Anthony Guy , Stefansson, Hreinn , Stefansson, Kari , Craig, John , Johnson, Michael R , Striano, Pasquale , Lerche, Holger , Furney, Simon , Delanty, Norman , Consortium EpiPGX , Sisodiya, Sanjay M , Cavalleri, Gianpiero L
    Publication 2023-11-01
  • Assessing the role of rare genetic variants in drug-resistant, non-lesional focal epilepsy.
    par Wolking, Stefan , Moreau, Claudia , McCormack, Mark , Krause, Roland , Krenn, Martin , EpiPGx Consortium , Berkovic, Samuel F , Cavalleri, Gianpiero L , Delanty, Norman , Depondt, Chantal , Johnson, Michael R , Koeleman, B.P.C. , Kunz, Wolfgang Gerhard , Lerche, Holger , Marson, Anthony Guy , O'Brien, Terence , Petrovski, Slave , Sander, Josemir W , Sills, Graeme , Striano, Pasquale , Zara, Federico , Zimprich, Fritz , Sisodiya, Sanjay M , Girard, S , Cossette, Patrick
    Publication 2021-07-01
  • Genomic and clinical predictors of lacosamide response in refractory epilepsies
    par Heavin, Sinead , McCormack, Mark , Wolking, Stefan , Slattery, Lisa , Walley, Nicole , Avbersek, Andreja , Novy, Jan , Sinha, Saurabh S.R. , Radtke, Rodney , Doherty, Colin P , Auce, Pauls , Craig, John , Johnson, Margaret , Koeleman, B.P.C. , Krause, Roland , Kunz, Wolfram W.S. , Marson, Anthony Guy , O'Brien, Terence John , Sander, Josemir W , Sills, Graeme , Stefansson, Hreinn , Striano, Pasquale , Zara, Federico , Depondt, Chantal , Sisodiya, Sanjay , Goldstein, David , Lerche, Holger , Cavalleri, Gianpiero , Delanty, Norman
    Publication 2019-10-01
  • Clinical outcomes among initial survivors of cryptogenic new-onset refractory status epilepsy (NORSE)
    par Costello, Daniel , Matthews, Elizabeth , Aurangzeb, Sidra , Doran, Elisabeth , Stack, Jessica , Wesselingh, Robb , Dugan, Patricia , Choi, Hyunmi , Depondt, Chantal , Devinsky, Orrin In , Doherty, Colin P , Kwan, Patrick , Monif, Mastura , O'Brien, Terence John , Sen, Arjune , Gaspard, Nicolas
    Publication 2024